

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.44764117 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.44764117 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.69470798 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.61042747 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.70619721 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 5.19194968 |
| 7 | positive thymic T cell selection (GO:0045059) | 4.94574992 |
| 8 | negative T cell selection (GO:0043383) | 4.85644579 |
| 9 | negative thymic T cell selection (GO:0045060) | 4.83050861 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.73268661 |
| 11 | * response to interleukin-15 (GO:0070672) | 4.52571651 |
| 12 | thymic T cell selection (GO:0045061) | 4.41335264 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 4.37197274 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.25927669 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.25927669 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.25927669 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.25927669 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.25927669 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.25927669 |
| 20 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.20254759 |
| 21 | tolerance induction (GO:0002507) | 4.19661730 |
| 22 | positive regulation of B cell differentiation (GO:0045579) | 4.16152941 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.12742391 |
| 24 | positive T cell selection (GO:0043368) | 4.11950086 |
| 25 | T cell migration (GO:0072678) | 4.09502626 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.08219098 |
| 27 | T cell selection (GO:0045058) | 4.07153241 |
| 28 | negative regulation of cell killing (GO:0031342) | 4.05516016 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.05516016 |
| 30 | detection of bacterium (GO:0016045) | 4.04557413 |
| 31 | detection of other organism (GO:0098543) | 4.04385161 |
| 32 | negative regulation of T cell mediated immunity (GO:0002710) | 4.01309834 |
| 33 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.96717974 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.96005040 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.93379958 |
| 36 | interferon-gamma production (GO:0032609) | 3.88467690 |
| 37 | regulation of B cell differentiation (GO:0045577) | 3.87125813 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 3.83548412 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.75581659 |
| 40 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.64583016 |
| 41 | cellular extravasation (GO:0045123) | 3.58744158 |
| 42 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.57381282 |
| 43 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.56374079 |
| 44 | macrophage activation involved in immune response (GO:0002281) | 3.54200522 |
| 45 | B cell receptor signaling pathway (GO:0050853) | 3.50092550 |
| 46 | regulation of tolerance induction (GO:0002643) | 3.50005964 |
| 47 | leukocyte aggregation (GO:0070486) | 3.48382537 |
| 48 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.47683471 |
| 49 | T cell receptor signaling pathway (GO:0050852) | 3.44523922 |
| 50 | positive regulation of interleukin-2 production (GO:0032743) | 3.41318926 |
| 51 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.39427626 |
| 52 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.39395427 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 3.39037219 |
| 54 | germinal center formation (GO:0002467) | 3.37973993 |
| 55 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.36511897 |
| 56 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.32439328 |
| 57 | neutrophil activation (GO:0042119) | 3.32220711 |
| 58 | defense response to protozoan (GO:0042832) | 3.32010962 |
| 59 | positive regulation of histone deacetylation (GO:0031065) | 3.31969848 |
| 60 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.30842578 |
| 61 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.30267775 |
| 62 | regulation of response to interferon-gamma (GO:0060330) | 3.25365331 |
| 63 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.25169563 |
| 64 | B cell mediated immunity (GO:0019724) | 3.23927142 |
| 65 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.23916408 |
| 66 | response to muramyl dipeptide (GO:0032495) | 3.23895154 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 3.23891696 |
| 68 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.22406828 |
| 69 | detection of external biotic stimulus (GO:0098581) | 3.22287941 |
| 70 | T cell costimulation (GO:0031295) | 3.22105859 |
| 71 | * T cell homeostasis (GO:0043029) | 3.21054213 |
| 72 | * negative regulation of interleukin-12 production (GO:0032695) | 3.20804681 |
| 73 | negative regulation of innate immune response (GO:0045824) | 3.20682520 |
| 74 | ribosomal small subunit assembly (GO:0000028) | 3.20657454 |
| 75 | regulation of regulatory T cell differentiation (GO:0045589) | 3.19746187 |
| 76 | respiratory burst (GO:0045730) | 3.19709839 |
| 77 | mature B cell differentiation (GO:0002335) | 3.18688115 |
| 78 | negative regulation of phagocytosis (GO:0050765) | 3.18517619 |
| 79 | regulation of T cell tolerance induction (GO:0002664) | 3.16253119 |
| 80 | lymphocyte costimulation (GO:0031294) | 3.16129499 |
| 81 | response to peptidoglycan (GO:0032494) | 3.15837225 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.15694496 |
| 83 | leukocyte degranulation (GO:0043299) | 3.13671815 |
| 84 | positive regulation of isotype switching (GO:0045830) | 3.13046918 |
| 85 | lymph node development (GO:0048535) | 3.11695819 |
| 86 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.09273256 |
| 87 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09115803 |
| 88 | * JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.08938253 |
| 89 | viral transcription (GO:0019083) | 3.07936077 |
| 90 | dendritic cell chemotaxis (GO:0002407) | 3.07495138 |
| 91 | granulocyte activation (GO:0036230) | 3.06490330 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 3.06462163 |
| 93 | natural killer cell differentiation (GO:0001779) | 3.06088344 |
| 94 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.05534686 |
| 95 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.01312762 |
| 96 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.00902981 |
| 97 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.00745434 |
| 98 | response to host immune response (GO:0052572) | 3.00745434 |
| 99 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.98908643 |
| 100 | dendritic cell migration (GO:0036336) | 2.95844055 |
| 101 | regulation of cell killing (GO:0031341) | 2.93765722 |
| 102 | regulation of interleukin-2 production (GO:0032663) | 2.93158507 |
| 103 | Peyers patch development (GO:0048541) | 2.91735530 |
| 104 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.91735530 |
| 105 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.90616575 |
| 106 | detection of biotic stimulus (GO:0009595) | 2.89282996 |
| 107 | translational termination (GO:0006415) | 2.89086188 |
| 108 | * negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.88914613 |
| 109 | megakaryocyte development (GO:0035855) | 2.88691804 |
| 110 | positive regulation of protein deacetylation (GO:0090312) | 2.87016037 |
| 111 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.86034032 |
| 112 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.86034032 |
| 113 | * lymphocyte homeostasis (GO:0002260) | 2.85147861 |
| 114 | positive regulation of humoral immune response (GO:0002922) | 2.84606133 |
| 115 | positive regulation of tolerance induction (GO:0002645) | 2.83724340 |
| 116 | myeloid dendritic cell activation (GO:0001773) | 2.83201017 |
| 117 | response to type I interferon (GO:0034340) | 2.83057275 |
| 118 | endothelial tube morphogenesis (GO:0061154) | 2.82891824 |
| 119 | morphogenesis of an endothelium (GO:0003159) | 2.82891824 |
| 120 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.81368222 |
| 121 | natural killer cell activation (GO:0030101) | 2.81006988 |
| 122 | mast cell activation (GO:0045576) | 2.79158802 |
| 123 | definitive hemopoiesis (GO:0060216) | 2.76039646 |
| 124 | cellular response to type I interferon (GO:0071357) | 2.75718730 |
| 125 | type I interferon signaling pathway (GO:0060337) | 2.75718730 |
| 126 | response to protozoan (GO:0001562) | 2.73158304 |
| 127 | leukocyte cell-cell adhesion (GO:0007159) | 2.72388379 |
| 128 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.70568269 |
| 129 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.70568269 |
| 130 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.70053829 |
| 131 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.68551341 |
| 132 | positive regulation of B cell mediated immunity (GO:0002714) | 2.68551341 |
| 133 | positive regulation of immunoglobulin production (GO:0002639) | 2.65242405 |
| 134 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.65179371 |
| 135 | activated T cell proliferation (GO:0050798) | 2.64403124 |
| 136 | myeloid dendritic cell differentiation (GO:0043011) | 2.63827703 |
| 137 | positive regulation of defense response to virus by host (GO:0002230) | 2.62409604 |
| 138 | immunoglobulin mediated immune response (GO:0016064) | 2.61836645 |
| 139 | T cell proliferation (GO:0042098) | 2.61354297 |
| 140 | regulation of isotype switching (GO:0045191) | 2.60394726 |
| 141 | positive regulation of granulocyte differentiation (GO:0030854) | 2.60134529 |
| 142 | * leukocyte homeostasis (GO:0001776) | 2.59477276 |
| 143 | mature B cell differentiation involved in immune response (GO:0002313) | 2.57043229 |
| 144 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.56912952 |
| 145 | positive regulation of DNA recombination (GO:0045911) | 2.56594774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.49472890 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.13481414 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.02332968 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.87347286 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.41353016 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.02722985 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.00943157 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86149844 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.79320317 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.78345072 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.69353956 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 2.59366539 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.47447061 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.47043972 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.46734622 |
| 16 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.40831044 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38741872 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.36685811 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.36235717 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34792135 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32623721 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.31385815 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.26745394 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.26006553 |
| 25 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.21679327 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.21291534 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05683324 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00468521 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.92036817 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88934406 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.86408784 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86092791 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.85572263 |
| 34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.85177850 |
| 35 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84410929 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84090868 |
| 37 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.84008827 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83203552 |
| 39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.80929312 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78944423 |
| 41 | * MAF_26560356_Chip-Seq_TH2_Human | 1.78661968 |
| 42 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75736347 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.74797961 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72982068 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.71251773 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70784196 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.66893348 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64782835 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62519620 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60785760 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.54407371 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50311834 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45148130 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41841532 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41840892 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40489812 |
| 57 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.38453760 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35999599 |
| 59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34785365 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34725452 |
| 61 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.33190926 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32218158 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30866389 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30479891 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23396026 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22984988 |
| 67 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22923808 |
| 68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20841693 |
| 69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.18840090 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17732575 |
| 71 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.16770335 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16383967 |
| 73 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14107988 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12108761 |
| 75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11803755 |
| 76 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11623724 |
| 77 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09711172 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09690640 |
| 79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09684318 |
| 80 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.09622984 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05839466 |
| 82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05717630 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04714540 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03086640 |
| 85 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02102718 |
| 86 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01218736 |
| 87 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00911865 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99828178 |
| 89 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.99622174 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98544475 |
| 91 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.98333953 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97001250 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95111953 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94626503 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94220533 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93743105 |
| 97 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93563136 |
| 98 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93141932 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92391047 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92223867 |
| 101 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.90455553 |
| 102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90368662 |
| 103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89738548 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89030077 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88375466 |
| 106 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87345413 |
| 107 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.87040002 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.86664003 |
| 109 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85560802 |
| 110 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85556984 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84843337 |
| 112 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.84211573 |
| 113 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.83656191 |
| 114 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83265520 |
| 115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83122680 |
| 116 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83018711 |
| 117 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81415019 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81003972 |
| 119 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80782622 |
| 120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80571172 |
| 121 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.80428431 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79988314 |
| 123 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.77863305 |
| 124 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.75481036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.81895931 |
| 2 | MP0000685_abnormal_immune_system | 3.44758389 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.32931201 |
| 4 | * MP0001800_abnormal_humoral_immune | 3.03069595 |
| 5 | MP0005671_abnormal_response_to | 3.01943152 |
| 6 | * MP0005387_immune_system_phenotype | 2.80336193 |
| 7 | * MP0001790_abnormal_immune_system | 2.80336193 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.79856087 |
| 9 | * MP0002396_abnormal_hematopoietic_system | 2.76729447 |
| 10 | * MP0002398_abnormal_bone_marrow | 2.55143976 |
| 11 | MP0003436_decreased_susceptibility_to | 2.49698271 |
| 12 | * MP0002723_abnormal_immune_serum | 2.48846167 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.46092586 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.45848188 |
| 15 | * MP0002420_abnormal_adaptive_immunity | 2.45594453 |
| 16 | MP0001873_stomach_inflammation | 2.41816836 |
| 17 | * MP0001819_abnormal_immune_cell | 2.41000039 |
| 18 | MP0003724_increased_susceptibility_to | 2.36015630 |
| 19 | MP0009785_altered_susceptibility_to | 2.31845737 |
| 20 | MP0004808_abnormal_hematopoietic_stem | 2.29543702 |
| 21 | MP0003303_peritoneal_inflammation | 2.29420022 |
| 22 | * MP0005025_abnormal_response_to | 2.24212036 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.22656596 |
| 24 | * MP0000716_abnormal_immune_system | 2.19372302 |
| 25 | * MP0000689_abnormal_spleen_morphology | 2.16693916 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.13483058 |
| 27 | * MP0002722_abnormal_immune_system | 2.13219297 |
| 28 | MP0002405_respiratory_system_inflammati | 2.09086687 |
| 29 | * MP0000703_abnormal_thymus_morphology | 2.04886611 |
| 30 | MP0005464_abnormal_platelet_physiology | 2.02168870 |
| 31 | * MP0010155_abnormal_intestine_physiology | 1.99957206 |
| 32 | MP0000465_gastrointestinal_hemorrhage | 1.95826777 |
| 33 | * MP0002429_abnormal_blood_cell | 1.93079704 |
| 34 | MP0009278_abnormal_bone_marrow | 1.91695012 |
| 35 | MP0002419_abnormal_innate_immunity | 1.85482523 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.77758983 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.77758983 |
| 38 | * MP0003866_abnormal_defecation | 1.75191087 |
| 39 | MP0001853_heart_inflammation | 1.70272640 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.70184714 |
| 41 | MP0004510_myositis | 1.63939717 |
| 42 | MP0002933_joint_inflammation | 1.63259985 |
| 43 | MP0002006_tumorigenesis | 1.60553978 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.58206282 |
| 45 | MP0004947_skin_inflammation | 1.57677511 |
| 46 | * MP0001845_abnormal_inflammatory_respons | 1.54384993 |
| 47 | MP0000490_abnormal_crypts_of | 1.52363874 |
| 48 | MP0006082_CNS_inflammation | 1.51623084 |
| 49 | MP0004381_abnormal_hair_follicle | 1.40072910 |
| 50 | MP0002132_abnormal_respiratory_system | 1.31165913 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.29698663 |
| 52 | MP0008057_abnormal_DNA_replication | 1.23012514 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.22555820 |
| 54 | MP0008469_abnormal_protein_level | 1.21608015 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.19134192 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.17199819 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.15057092 |
| 58 | MP0000858_altered_metastatic_potential | 1.12658582 |
| 59 | MP0008260_abnormal_autophagy | 1.11945754 |
| 60 | MP0010094_abnormal_chromosome_stability | 1.09710727 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.08447502 |
| 62 | MP0003077_abnormal_cell_cycle | 1.06524273 |
| 63 | MP0001851_eye_inflammation | 1.05512536 |
| 64 | MP0001879_abnormal_lymphatic_vessel | 1.00729943 |
| 65 | MP0003448_altered_tumor_morphology | 1.00218347 |
| 66 | MP0008961_abnormal_basal_metabolism | 0.99227173 |
| 67 | MP0005670_abnormal_white_adipose | 0.99037330 |
| 68 | MP0005310_abnormal_salivary_gland | 0.98383584 |
| 69 | MP0003828_pulmonary_edema | 0.98047167 |
| 70 | MP0005174_abnormal_tail_pigmentation | 0.97739303 |
| 71 | MP0005451_abnormal_body_composition | 0.96481477 |
| 72 | MP0004883_abnormal_blood_vessel | 0.93676716 |
| 73 | MP0005023_abnormal_wound_healing | 0.91390059 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.91296438 |
| 75 | MP0005076_abnormal_cell_differentiation | 0.90255186 |
| 76 | MP0001986_abnormal_taste_sensitivity | 0.89532691 |
| 77 | MP0003693_abnormal_embryo_hatching | 0.87986373 |
| 78 | MP0003566_abnormal_cell_adhesion | 0.87269605 |
| 79 | MP0005166_decreased_susceptibility_to | 0.86318939 |
| 80 | MP0003111_abnormal_nucleus_morphology | 0.84078861 |
| 81 | MP0002009_preneoplasia | 0.83591999 |
| 82 | MP0006054_spinal_hemorrhage | 0.81884865 |
| 83 | MP0003075_altered_response_to | 0.81681968 |
| 84 | MP0009763_increased_sensitivity_to | 0.80605236 |
| 85 | MP0000609_abnormal_liver_physiology | 0.79234256 |
| 86 | MP0009840_abnormal_foam_cell | 0.78151767 |
| 87 | MP0005390_skeleton_phenotype | 0.76407265 |
| 88 | MP0000343_altered_response_to | 0.75990374 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.75834633 |
| 90 | MP0008007_abnormal_cellular_replicative | 0.75701980 |
| 91 | MP0010307_abnormal_tumor_latency | 0.75207393 |
| 92 | MP0000313_abnormal_cell_death | 0.72157929 |
| 93 | MP0004957_abnormal_blastocyst_morpholog | 0.70657436 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.70301446 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 0.70204405 |
| 96 | * MP0000477_abnormal_intestine_morphology | 0.67833072 |
| 97 | MP0009764_decreased_sensitivity_to | 0.67612248 |
| 98 | MP0003172_abnormal_lysosome_physiology | 0.66836706 |
| 99 | MP0000249_abnormal_blood_vessel | 0.65971136 |
| 100 | MP0000598_abnormal_liver_morphology | 0.65325762 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.65222553 |
| 102 | MP0008058_abnormal_DNA_repair | 0.65084906 |
| 103 | MP0000350_abnormal_cell_proliferation | 0.64458996 |
| 104 | MP0005164_abnormal_response_to | 0.64365716 |
| 105 | MP0001663_abnormal_digestive_system | 0.62844331 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.62595560 |
| 107 | MP0002086_abnormal_extraembryonic_tissu | 0.62525084 |
| 108 | MP0005666_abnormal_adipose_tissue | 0.61330729 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.60466741 |
| 110 | MP0003045_fibrosis | 0.58477884 |
| 111 | MP0003795_abnormal_bone_structure | 0.58048080 |
| 112 | MP0002088_abnormal_embryonic_growth/wei | 0.57972969 |
| 113 | MP0003943_abnormal_hepatobiliary_system | 0.57832434 |
| 114 | MP0000604_amyloidosis | 0.57237235 |
| 115 | MP0003984_embryonic_growth_retardation | 0.56677903 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.56316037 |
| 117 | MP0001915_intracranial_hemorrhage | 0.56283332 |
| 118 | MP0002254_reproductive_system_inflammat | 0.56262714 |
| 119 | MP0008873_increased_physiological_sensi | 0.55337225 |
| 120 | MP0008004_abnormal_stomach_pH | 0.52393596 |
| 121 | MP0003690_abnormal_glial_cell | 0.49976625 |
| 122 | MP0005381_digestive/alimentary_phenotyp | 0.49787095 |
| 123 | MP0008874_decreased_physiological_sensi | 0.48643698 |
| 124 | MP0001348_abnormal_lacrimal_gland | 0.46639155 |
| 125 | MP0004130_abnormal_muscle_cell | 0.44765098 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.43578387 |
| 127 | MP0005319_abnormal_enzyme/_coenzyme | 0.43246533 |
| 128 | MP0003252_abnormal_bile_duct | 0.41595131 |
| 129 | MP0005058_abnormal_lysosome_morphology | 0.40592574 |
| 130 | MP0002928_abnormal_bile_duct | 0.40366436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 5.21930703 |
| 2 | IgM deficiency (HP:0002850) | 5.21569087 |
| 3 | Nasal polyposis (HP:0100582) | 4.62114248 |
| 4 | Abnormality of the nasal mucosa (HP:0000433) | 4.58043997 |
| 5 | Recurrent bronchitis (HP:0002837) | 4.55734024 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.50622127 |
| 7 | Recurrent viral infections (HP:0004429) | 4.30227627 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.23980450 |
| 9 | T lymphocytopenia (HP:0005403) | 4.22456932 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.21885372 |
| 11 | Myositis (HP:0100614) | 4.09606410 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.05991030 |
| 13 | Abnormality of T cell number (HP:0011839) | 3.98063714 |
| 14 | Thrombocytosis (HP:0001894) | 3.93923252 |
| 15 | Inflammation of the large intestine (HP:0002037) | 3.92552942 |
| 16 | Spontaneous hematomas (HP:0007420) | 3.90171627 |
| 17 | Gastrointestinal inflammation (HP:0004386) | 3.90136630 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.73795335 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.73795335 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.65550992 |
| 21 | Abnormality of the fingertips (HP:0001211) | 3.61245465 |
| 22 | Eczematoid dermatitis (HP:0000976) | 3.59100532 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.58232031 |
| 24 | * Abnormality of T cells (HP:0002843) | 3.53829397 |
| 25 | Keratoconjunctivitis (HP:0001096) | 3.47990490 |
| 26 | Prolonged bleeding time (HP:0003010) | 3.42391236 |
| 27 | Pustule (HP:0200039) | 3.37957744 |
| 28 | Colitis (HP:0002583) | 3.27401879 |
| 29 | Increased IgM level (HP:0003496) | 3.11344808 |
| 30 | Agammaglobulinemia (HP:0004432) | 3.07043623 |
| 31 | Cellulitis (HP:0100658) | 3.06972551 |
| 32 | Increased IgE level (HP:0003212) | 3.05749830 |
| 33 | Lymphopenia (HP:0001888) | 3.03805804 |
| 34 | IgA deficiency (HP:0002720) | 3.00432850 |
| 35 | Hypochromic anemia (HP:0001931) | 2.97428052 |
| 36 | Chronic diarrhea (HP:0002028) | 2.96490813 |
| 37 | Epistaxis (HP:0000421) | 2.94716041 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.94633484 |
| 39 | Recurrent abscess formation (HP:0002722) | 2.85470874 |
| 40 | Urticaria (HP:0001025) | 2.85073061 |
| 41 | Vasculitis (HP:0002633) | 2.83119394 |
| 42 | Gingivitis (HP:0000230) | 2.82725316 |
| 43 | * Abnormality of T cell physiology (HP:0011840) | 2.81849615 |
| 44 | * Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.81420568 |
| 45 | Interstitial pulmonary disease (HP:0006530) | 2.77936864 |
| 46 | * Meningitis (HP:0001287) | 2.76411119 |
| 47 | Gastrointestinal stroma tumor (HP:0100723) | 2.75525318 |
| 48 | B lymphocytopenia (HP:0010976) | 2.74996442 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.74996442 |
| 50 | Hypochromic microcytic anemia (HP:0004840) | 2.70633971 |
| 51 | Hemoptysis (HP:0002105) | 2.66534384 |
| 52 | Recurrent skin infections (HP:0001581) | 2.66378436 |
| 53 | Verrucae (HP:0200043) | 2.66362384 |
| 54 | Papilloma (HP:0012740) | 2.66362384 |
| 55 | Stomatitis (HP:0010280) | 2.66058102 |
| 56 | Chronic sinusitis (HP:0011109) | 2.66010221 |
| 57 | Abnormal platelet volume (HP:0011876) | 2.66008232 |
| 58 | Chest pain (HP:0100749) | 2.65546140 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.64035220 |
| 60 | IgG deficiency (HP:0004315) | 2.63577678 |
| 61 | * Panhypogammaglobulinemia (HP:0003139) | 2.62602040 |
| 62 | Emphysema (HP:0002097) | 2.61481138 |
| 63 | Basal cell carcinoma (HP:0002671) | 2.59140182 |
| 64 | Anorexia (HP:0002039) | 2.58535697 |
| 65 | Lymphoma (HP:0002665) | 2.57274693 |
| 66 | Recurrent sinusitis (HP:0011108) | 2.56358619 |
| 67 | Gingival bleeding (HP:0000225) | 2.56268274 |
| 68 | Abnormality of the pleura (HP:0002103) | 2.53529231 |
| 69 | Petechiae (HP:0000967) | 2.52588629 |
| 70 | Abnormal platelet function (HP:0011869) | 2.50258913 |
| 71 | Impaired platelet aggregation (HP:0003540) | 2.50258913 |
| 72 | Gangrene (HP:0100758) | 2.49578888 |
| 73 | Combined immunodeficiency (HP:0005387) | 2.49479535 |
| 74 | Mediastinal lymphadenopathy (HP:0100721) | 2.48458306 |
| 75 | Papilledema (HP:0001085) | 2.48097372 |
| 76 | Arterial thrombosis (HP:0004420) | 2.47214455 |
| 77 | Orchitis (HP:0100796) | 2.44069319 |
| 78 | Severe combined immunodeficiency (HP:0004430) | 2.43578768 |
| 79 | Bronchitis (HP:0012387) | 2.43208955 |
| 80 | Recurrent bacterial skin infections (HP:0005406) | 2.41057961 |
| 81 | Eosinophilia (HP:0001880) | 2.38338960 |
| 82 | Episodic fever (HP:0001954) | 2.35860597 |
| 83 | Granulocytopenia (HP:0001913) | 2.35349969 |
| 84 | Increased density of long bones (HP:0006392) | 2.34964470 |
| 85 | Leukocytosis (HP:0001974) | 2.33788828 |
| 86 | Hematochezia (HP:0002573) | 2.32787187 |
| 87 | Encephalitis (HP:0002383) | 2.32180005 |
| 88 | Reticulocytopenia (HP:0001896) | 2.29977815 |
| 89 | Abnormality of the prostate (HP:0008775) | 2.29042872 |
| 90 | Joint swelling (HP:0001386) | 2.28609255 |
| 91 | Abnormality of eosinophils (HP:0001879) | 2.25565293 |
| 92 | Pulmonary infiltrates (HP:0002113) | 2.23523819 |
| 93 | Acute myeloid leukemia (HP:0004808) | 2.21614049 |
| 94 | Cheilitis (HP:0100825) | 2.20526604 |
| 95 | Amaurosis fugax (HP:0100576) | 2.19991588 |
| 96 | Obstructive lung disease (HP:0006536) | 2.19126757 |
| 97 | Chronic obstructive pulmonary disease (HP:0006510) | 2.19126757 |
| 98 | Sepsis (HP:0100806) | 2.18920147 |
| 99 | Stomach cancer (HP:0012126) | 2.17631636 |
| 100 | Pulmonary embolism (HP:0002204) | 2.16662218 |
| 101 | Poikiloderma (HP:0001029) | 2.16420647 |
| 102 | Retrobulbar optic neuritis (HP:0100654) | 2.15757458 |
| 103 | Optic neuritis (HP:0100653) | 2.15757458 |
| 104 | Keratitis (HP:0000491) | 2.14700241 |
| 105 | Skin ulcer (HP:0200042) | 2.14643862 |
| 106 | Acute hepatic failure (HP:0006554) | 2.12458563 |
| 107 | Premature loss of primary teeth (HP:0006323) | 2.12167027 |
| 108 | Glomerulopathy (HP:0100820) | 2.10650634 |
| 109 | Increased mean platelet volume (HP:0011877) | 2.08185279 |
| 110 | Fatigue (HP:0012378) | 2.06040696 |
| 111 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.04957539 |
| 112 | Skin rash (HP:0000988) | 2.04302434 |
| 113 | Periodontitis (HP:0000704) | 2.03943532 |
| 114 | Thyroiditis (HP:0100646) | 2.02247592 |
| 115 | Microcytic anemia (HP:0001935) | 2.01795628 |
| 116 | Restrictive lung disease (HP:0002091) | 1.96448398 |
| 117 | Abnormal number of erythroid precursors (HP:0012131) | 1.96011641 |
| 118 | Abnormality of the endocardium (HP:0004306) | 1.95958525 |
| 119 | Polyneuropathy (HP:0001271) | 1.94889515 |
| 120 | Hypergammaglobulinemia (HP:0010702) | 1.93895975 |
| 121 | Persistence of primary teeth (HP:0006335) | 1.93754579 |
| 122 | Polycythemia (HP:0001901) | 1.93713969 |
| 123 | Leukopenia (HP:0001882) | 1.93515490 |
| 124 | Viral hepatitis (HP:0006562) | 1.93151518 |
| 125 | Arthralgia (HP:0002829) | 1.91636906 |
| 126 | Hyperacusis (HP:0010780) | 1.87596657 |
| 127 | Autoimmune hemolytic anemia (HP:0001890) | 1.86594619 |
| 128 | Osteomyelitis (HP:0002754) | 1.81085303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.69012219 |
| 2 | RIPK4 | 3.87067552 |
| 3 | EEF2K | 3.57225829 |
| 4 | TXK | 2.90179110 |
| 5 | KDR | 2.47591642 |
| 6 | PKN2 | 2.47026657 |
| 7 | TYK2 | 2.34194508 |
| 8 | ZAP70 | 2.33950979 |
| 9 | FGFR4 | 2.28570790 |
| 10 | TRIB3 | 2.23999651 |
| 11 | * JAK3 | 2.22682482 |
| 12 | MAP3K10 | 2.14882038 |
| 13 | STK10 | 2.14522271 |
| 14 | PRPF4B | 2.10624761 |
| 15 | GRK6 | 1.92702905 |
| 16 | KIT | 1.88457593 |
| 17 | BTK | 1.85724214 |
| 18 | ITK | 1.82325061 |
| 19 | TGFBR2 | 1.82306107 |
| 20 | BLK | 1.79169355 |
| 21 | JAK1 | 1.71369657 |
| 22 | FLT3 | 1.69991467 |
| 23 | CSF1R | 1.68620624 |
| 24 | ERN1 | 1.64515089 |
| 25 | EPHB1 | 1.61240792 |
| 26 | IKBKE | 1.54751915 |
| 27 | TIE1 | 1.51191044 |
| 28 | TEC | 1.49323408 |
| 29 | TBK1 | 1.47802088 |
| 30 | MAP2K3 | 1.45469024 |
| 31 | CDK12 | 1.43777550 |
| 32 | MAP3K14 | 1.43662398 |
| 33 | TGFBR1 | 1.42179950 |
| 34 | SIK2 | 1.39942069 |
| 35 | FGFR3 | 1.37220559 |
| 36 | SYK | 1.36504899 |
| 37 | * LCK | 1.35419494 |
| 38 | NLK | 1.33346287 |
| 39 | LRRK2 | 1.32904222 |
| 40 | HCK | 1.25194176 |
| 41 | NME2 | 1.24021258 |
| 42 | CLK1 | 1.20920827 |
| 43 | CSK | 1.15974371 |
| 44 | MAP3K3 | 1.07166321 |
| 45 | SIK1 | 1.06475583 |
| 46 | CDK4 | 1.03852560 |
| 47 | FES | 1.03148648 |
| 48 | EPHA3 | 1.03092935 |
| 49 | IKBKB | 1.02984003 |
| 50 | FGR | 1.02205790 |
| 51 | PIM1 | 1.01651550 |
| 52 | BMPR2 | 1.01083697 |
| 53 | JAK2 | 0.99825429 |
| 54 | PTK6 | 0.98177509 |
| 55 | IRAK4 | 0.96792856 |
| 56 | MAP3K7 | 0.94777771 |
| 57 | TTN | 0.92470078 |
| 58 | NEK2 | 0.90449365 |
| 59 | RPS6KA4 | 0.86754071 |
| 60 | MAP3K13 | 0.85645086 |
| 61 | MAP3K1 | 0.84082185 |
| 62 | MARK3 | 0.83571192 |
| 63 | SMG1 | 0.81279941 |
| 64 | CAMKK2 | 0.80654653 |
| 65 | RPS6KB2 | 0.79581656 |
| 66 | LYN | 0.76755485 |
| 67 | MAP2K6 | 0.76125763 |
| 68 | CHUK | 0.75890976 |
| 69 | TNK2 | 0.74165973 |
| 70 | IRAK3 | 0.73706792 |
| 71 | CAMKK1 | 0.71023964 |
| 72 | ALK | 0.68691323 |
| 73 | HIPK2 | 0.67148957 |
| 74 | SIK3 | 0.66926765 |
| 75 | PASK | 0.66674767 |
| 76 | MATK | 0.66247249 |
| 77 | TAOK3 | 0.65991933 |
| 78 | PRKCH | 0.64856036 |
| 79 | CDC42BPA | 0.63428244 |
| 80 | MAPK7 | 0.63248561 |
| 81 | CDC7 | 0.60746360 |
| 82 | PIK3CG | 0.60651806 |
| 83 | FYN | 0.60198480 |
| 84 | PRKCQ | 0.56679089 |
| 85 | YES1 | 0.55853148 |
| 86 | CDK9 | 0.52602773 |
| 87 | MAP3K11 | 0.52334652 |
| 88 | CAMK1D | 0.51219011 |
| 89 | BRD4 | 0.50758364 |
| 90 | TSSK6 | 0.49335601 |
| 91 | MAP3K8 | 0.49112708 |
| 92 | PRKD2 | 0.48358962 |
| 93 | MAPK11 | 0.47669334 |
| 94 | STK4 | 0.46459238 |
| 95 | CDK6 | 0.46095458 |
| 96 | TAOK2 | 0.45877996 |
| 97 | PDK1 | 0.45853183 |
| 98 | MAPK4 | 0.44246504 |
| 99 | GRK7 | 0.43983606 |
| 100 | MARK2 | 0.41934622 |
| 101 | PTK2B | 0.41247273 |
| 102 | STK11 | 0.40284974 |
| 103 | MAP2K2 | 0.40266192 |
| 104 | RPS6KA6 | 0.40216576 |
| 105 | PDPK1 | 0.38837579 |
| 106 | TAOK1 | 0.38775025 |
| 107 | PIM2 | 0.37462598 |
| 108 | TRPM7 | 0.37438523 |
| 109 | MAPKAPK2 | 0.35454349 |
| 110 | ATR | 0.35142792 |
| 111 | IRAK2 | 0.34484012 |
| 112 | MTOR | 0.34461721 |
| 113 | MELK | 0.33902776 |
| 114 | CDK7 | 0.32557164 |
| 115 | RPS6KC1 | 0.31657211 |
| 116 | RPS6KL1 | 0.31657211 |
| 117 | MAPK3 | 0.29633777 |
| 118 | CAMK1G | 0.29121096 |
| 119 | RET | 0.29023799 |
| 120 | KSR2 | 0.28811360 |
| 121 | EGFR | 0.27452521 |
| 122 | RIPK1 | 0.27219131 |
| 123 | MAP3K5 | 0.26034535 |
| 124 | PAK4 | 0.25656189 |
| 125 | SGK3 | 0.25244486 |
| 126 | MAPK12 | 0.25179602 |
| 127 | TESK2 | 0.25171170 |
| 128 | IRAK1 | 0.25109993 |
| 129 | CDK19 | 0.24856736 |
| 130 | ABL1 | 0.24694242 |
| 131 | PRKCD | 0.23224756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 3.99292639 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.92646759 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.70878272 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.62026209 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.58908061 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.52298527 |
| 7 | * Measles_Homo sapiens_hsa05162 | 2.36393958 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.29905962 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.25661931 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.21977666 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10162589 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.09799480 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.09001144 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.08579492 |
| 15 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.91905134 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.91675632 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.76779929 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.72144409 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68324969 |
| 20 | Mismatch repair_Homo sapiens_hsa03430 | 1.58600188 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.56206049 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50829158 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48347012 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46018450 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42624635 |
| 26 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41968256 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.35367359 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32559488 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.31950560 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.28802046 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.26019389 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25695380 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23695816 |
| 34 | Platelet activation_Homo sapiens_hsa04611 | 1.20285649 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.16365406 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15088494 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15029219 |
| 38 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.13555279 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12582427 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12154038 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.12135401 |
| 42 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11188964 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.09781528 |
| 44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09489423 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07304436 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05697031 |
| 47 | Spliceosome_Homo sapiens_hsa03040 | 1.04207056 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.03809533 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03047116 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99889875 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98086654 |
| 52 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95389043 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 0.95018123 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.94314118 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93092799 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91820217 |
| 57 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88131007 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.87223819 |
| 59 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86210101 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.85020857 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83444381 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.82365264 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 0.80464647 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.79570656 |
| 65 | Homologous recombination_Homo sapiens_hsa03440 | 0.77401685 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.76304280 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.76108956 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74565634 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74020708 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.72837126 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72382401 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71538289 |
| 73 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71149135 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69623865 |
| 75 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69572264 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63847603 |
| 77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.63596223 |
| 78 | RNA transport_Homo sapiens_hsa03013 | 0.62510671 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61961175 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61684514 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61659779 |
| 82 | Cell cycle_Homo sapiens_hsa04110 | 0.58805398 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57492285 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.56647872 |
| 85 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.55453793 |
| 86 | RNA degradation_Homo sapiens_hsa03018 | 0.54871994 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53443222 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.51196471 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.49674545 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49111028 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48721651 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48427312 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48060208 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47003814 |
| 95 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46777722 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46478200 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45916217 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45112938 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44726472 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44351519 |
| 101 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.44320664 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44110571 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42836461 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42736828 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41576356 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41473833 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39646916 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.39574542 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.39564787 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39155658 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39146122 |
| 112 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.38725323 |
| 113 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.38278225 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37922849 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37598058 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36414061 |
| 117 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36316938 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35528124 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33986934 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32305513 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31788508 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30362887 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29658847 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.26800680 |
| 125 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24682648 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23588728 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23411914 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.23408935 |
| 129 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.21905270 |
| 130 | Prostate cancer_Homo sapiens_hsa05215 | 0.20182950 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.17362964 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17058724 |
| 133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.15005498 |

